Seeing Is Believing
Currently out of the existing stock ratings of Nicholas Joseph, 68 are a HOLD (73.12%), 21 are a BUY (22.58%), 4 are a SELL (4.3%).
Analyst Nicholas Joseph, currently employed at CITI, carries an average stock price target met ratio of 70.7% that have a potential upside of 20.2% achieved within 245 days.
Nicholas Joseph’s has documented 173 price targets and ratings displayed on 21 stocks.
Most recent stock forecast was given on SBRA, Sabra Healthcare REIT at 13-Sep-2024.
Analyst best performing recommendations are on WELL (WELLTOWER).
The best stock recommendation documented was for WELL (WELLTOWER) at 4/7/2020. The price target of $42 was fulfilled within 1 day with a profit of $3.26 (8.42%) receiving and performance score of 84.15.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$31
$-8.08 (-20.68%)
$33
8 months 24 days ago
(28-Feb-2024)
2/3 (66.67%)
$0.88 (2.92%)
42
Hold
$34
$-5.08 (-13.00%)
$43
8 months 30 days ago
(22-Feb-2024)
2/4 (50%)
$2.8 (8.97%)
331
Buy
$41
1 years 2 months 24 days ago
(28-Aug-2023)
3/9 (33.33%)
$6.49 (18.81%)
290
Hold
$39
$-0.08 (-0.20%)
$43
1 years 3 months ago
(21-Aug-2023)
2/2 (100%)
$7.17 (22.53%)
232
Buy
$42
$2.92 (7.47%)
$39
1 years 4 months 3 days ago
(18-Jul-2023)
1/3 (33.33%)
$7.96 (23.38%)
467
Which stock is Nicholas Joseph is most bullish on?
Which stock is Nicholas Joseph is most reserved on?
What Year was the first public recommendation made by Nicholas Joseph?